• Home
  • About Us
  • Getting Finances Done
    • Hiring Advisors
    • Debt Management
    • Spending Plan
  • Insurance
    • Life Insurance
    • Health Insurance
    • Disability Insurance
    • Homeowners/Renters Insurance
  • Contact Us
  • Our Editorial Commitment

The Free Financial Advisor

You are here: Home / Archives for Inflation Reduction Act

IRS Raises Clean Electricity Production Tax Credit to 3.1 Cents Per Kilowatt-Hour for 2026

September 8, 2026 by Amanda Blankenship Leave a Comment

2026 Clean Electricity Production Credit
The IRS has set the 2026 Clean Electricity Production Credit at 0.6 cents per kilowatt-hour for the base rate and 3.1 cents per kilowatt-hour for qualifying facilities eligible for the higher rate. Sunday Stock/Shutterstock

Clean electricity producers may qualify for a federal tax credit of up to 3.1 cents per kilowatt-hour in 2026 after the IRS published its annual inflation adjustment for the Clean Electricity Production Credit. The IRS announced the updated amounts in a Federal Register notice published September 4. The credit, established under Section 45Y of the Internal Revenue Code, provides a tax incentive based on the amount of qualifying clean electricity a taxpayer produces.

For 2026, the inflation-adjusted base credit is 0.6 cents per kilowatt-hour, while qualifying facilities eligible for the higher alternative amount can receive 3.1 cents per kilowatt-hour.

The Higher Credit Increased From 3 Cents to 3.1 Cents

Section 45Y starts with statutory amounts of 0.3 cents per kilowatt-hour for the base credit and 1.5 cents for the higher alternative credit. Those figures are adjusted for inflation each year.

For 2026, the IRS calculated an inflation adjustment factor of 2.0570, using the 2025 GDP implicit price deflator of 128.986 and the 1992 figure of 62.707.

After applying the adjustment and the rounding rules required under Section 45Y, the 2026 base amount remains 0.6 cents per kilowatt-hour, while the higher amount rises to 3.1 cents. In comparison, the inflation-adjusted rates for 2025 were 0.6 cents and 3 cents per kilowatt-hour, respectively.

Who Can Qualify for the 3.1-Cent Rate?

Not every qualifying clean electricity facility receives the higher rate. The alternative amount generally applies when a qualified facility has a maximum net output of less than one megawatt, began construction before January 29, 2023, or meets applicable prevailing-wage and apprenticeship requirements.

Facilities that don’t satisfy the requirements for the alternative amount generally receive the lower base rate. The Clean Electricity Production Credit is technology-neutral and focuses on greenhouse gas emissions rather than limiting eligibility to a short list of specific renewable technologies.

A qualified facility generally must generate electricity, have been placed in service after 2024 and have a greenhouse gas emissions rate that isn’t greater than zero. Special rules can also apply to new units or additions of capacity at older facilities.

What Could the Credit Be Worth?

Because Section 45Y is based on electricity production, the financial value of the credit can become significant as output increases. For a simple illustration, 1 million qualifying kilowatt-hours multiplied by the 3.1-cent 2026 rate equals $31,000 before considering other requirements, limitations or potential increases.

At the 0.6-cent base rate, the same 1 million kilowatt-hours would produce a $6,000 credit before other applicable rules.

Those examples don’t mean every facility generating that amount of electricity will receive those exact tax benefits. Eligibility, qualifying production, facility characteristics and compliance with the tax code all matter. Still, they demonstrate why what looks like a tiny fraction of a dollar per kilowatt-hour can translate into substantial tax value for larger clean-energy projects.

Some Facilities Can Qualify for Additional Increases

The inflation-adjusted rate isn’t necessarily the end of the calculation. Section 45Y provides a 10% increase for qualifying facilities located in designated energy communities. The IRS also provides for a domestic-content bonus when a facility satisfies requirements involving domestically produced steel, iron and manufactured products.

Those incentives can affect the economics of developing and operating qualifying clean-energy facilities, making location, construction practices and sourcing financially important considerations. Businesses considering the credit should determine which provisions apply to a specific facility rather than assuming the published 3.1-cent figure represents the final credit available for every project.

The Credit Is Claimed on Form 7211

Taxpayers claiming the Section 45Y Clean Electricity Production Credit generally use Form 7211, Clean Electricity Production Credit. The IRS says taxpayers must complete a separate Form 7211 for each qualified facility when required to claim the credit. The credit can also be eligible for provisions allowing certain taxpayers to transfer credits to unrelated parties for cash. Certain tax-exempt and governmental entities may instead qualify for elective payment provisions.

Pre-filing registration is required for taxpayers using applicable transfer or elective-payment provisions. Businesses should also be aware that a Section 45Y credit generally can’t be claimed for the same facility when certain other federal energy credits have already been claimed for that facility.

Why the 2026 Adjustment Matters

The September IRS notice doesn’t create a new clean-energy tax credit. Instead, it establishes the inflation-adjusted amounts used to calculate an existing credit for electricity produced, sold, consumed or stored during calendar year 2026. For facilities qualifying for the higher rate, the adjustment raises the applicable amount from 3 cents per kilowatt-hour in 2025 to 3.1 cents in 2026.

That one-tenth-of-a-cent difference may sound insignificant to an individual household, but at commercial electricity-production levels it can add up quickly. A facility with 100 million qualifying kilowatt-hours, for example, would see a $100,000 difference between a 3-cent and 3.1-cent rate before considering all other eligibility rules and adjustments.

Clean-energy producers, developers and their tax advisers should therefore use the new 2026 rates when estimating the value of qualifying Section 45Y production and confirm that the facility satisfies the requirements for the particular credit rate and any additional increases being claimed.

What to Read Next

6 Retirement Expenses That Can Rise Even When Inflation Slows

Why Grocery Inflation Feels Worse at Checkout Than It Looks on Paper

5 Bills That Quietly Got More Expensive This Year While Everyone Was Watching Inflation

Amanda Blankenship

Amanda Blankenship is the Chief Editor for District Media.  With a BA in journalism from Wingate University, she frequently writes for a handful of websites and loves to share her own personal finance story with others. When she isn’t typing away at her desk, she enjoys spending time with her daughter, son, husband, and dog. During her free time, you’re likely to find her with her nose in a book, hiking, or playing RPG video games.

Filed Under: news Tagged With: business taxes, clean electricity, clean electricity production, clean energy tax credit, energy tax credits, Inflation Reduction Act, IRS, renewable energy, Section 45Y, tax credits

Part D Costs Are Rising for Seniors on Fixed Incomes Despite New Reform Rules

June 16, 2026 by Brandon Marcus Leave a Comment

Part D Costs Are Rising for Seniors on Fixed Incomes Despite New Reform Rules
Medicare Part D costs continue to rise for many seniors despite new reforms, as premiums, copays, and drug pricing structures shift. Careful plan review and smart prescription choices can help reduce financial strain on fixed retirement incomes. Shutterstock

Prescription drug bills continue to squeeze retirement budgets, even as lawmakers introduce new Medicare changes meant to bring relief. Seniors enrolled in Medicare Part D now face a confusing mix of savings caps, rising premiums, and shifting plan structures. Many households expected reforms to ease financial pressure more quickly, but costs still climb in unexpected ways. Drug pricing trends, insurance design changes, and regional plan differences all play a role in the ongoing increases.

Fixed incomes make these shifts even more stressful, especially when medication needs stay constant or grow with age. The gap between policy promises and real-world savings feels wider than many expected. This situation demands a closer look at what actually drives these rising expenses.

Why Part D Costs Keep Climbing for Seniors

Medicare Part D costs continue rising because insurance plans adjust premiums and deductibles each year to match higher drug spending. Pharmaceutical companies also set list prices that increase faster than inflation for many brand-name medications. Seniors often feel these increases first through monthly plan premiums and pharmacy copays. Even small percentage changes create noticeable budget strain when income stays fixed. Many retirees rely on multiple prescriptions, which multiplies the impact of every price adjustment.

Another key pressure comes from plan competition that shifts rather than reduces overall costs. Insurance companies redesign coverage tiers instead of absorbing higher drug expenses themselves. Formularies change regularly, which pushes some medications into higher-cost categories. Seniors then face surprise increases even when they stay in the same plan year after year. These combined factors create a steady upward pressure on out-of-pocket spending.

What the New Reform Rules Actually Change

Recent Medicare reforms introduced a major out-of-pocket cap on Part D spending, designed to protect seniors from extreme annual costs. Starting in 2025, beneficiaries no longer pay more than a set amount for covered prescription drugs each year. This change offers meaningful relief for individuals with high-cost medications like cancer treatments or specialty biologics. However, the cap does not directly lower monthly premiums or everyday copays. Seniors still feel financial strain long before reaching the yearly limit.

The reforms also shift more financial responsibility to insurance companies and drug manufacturers. Plans now negotiate differently with pharmaceutical companies to manage risk under the new structure. Some insurers respond by adjusting premiums upward to balance their costs. Others reduce coverage flexibility or change drug tiers to protect profit margins. These adjustments mean seniors see mixed results depending on their specific plan and medication needs.

Hidden Drivers Behind Rising Prescription Costs

Drug pricing complexity drives many of the cost increases that seniors experience at the pharmacy counter. Pharmacy benefit managers negotiate rebates that rarely pass fully to consumers. These hidden pricing layers make it difficult for seniors to predict real medication costs. Brand-name drugs often maintain high prices even after years on the market. Generic alternatives help, but not all prescriptions offer lower-cost substitutes.

Another driver comes from the increasing use of specialty medications that treat chronic and complex conditions. These drugs often carry extremely high list prices that put insurance systems under pressure. Even with Medicare coverage, coinsurance rates for specialty tiers remain expensive. Seniors managing conditions like rheumatoid arthritis or diabetes feel this burden most strongly. Rising demand for these medications continues to reshape overall Part D spending trends.

How Seniors Can Respond and Reduce Out-of-Pocket Pressure

Seniors can reduce costs by reviewing Part D plans during every open enrollment period instead of automatically renewing coverage. Plan comparisons often reveal significant differences in drug pricing for identical prescriptions. Switching plans can lower annual spending even when monthly premiums look similar. Many seniors also save money by using preferred pharmacies within their plan networks. Small changes in pharmacy choice sometimes create surprisingly large savings over time.

Doctors and pharmacists also play a key role in cost management strategies. Requesting generic alternatives or therapeutic substitutes can significantly reduce copays. Some seniors benefit from 90-day mail-order prescriptions that lower per-dose costs. Prescription assistance programs from manufacturers or nonprofit groups also help eligible individuals. Careful coordination between healthcare providers and insurance plans helps reduce unnecessary spending.

What Experts Expect Next for Part D Pricing

Healthcare analysts expect Part D costs to remain volatile as insurers adjust to new federal rules. The out-of-pocket cap may stabilize extreme cases, but it will not fully stop annual premium increases. Drugmakers continue investing in high-cost specialty treatments that reshape insurance pricing models. These trends suggest long-term pressure on Medicare budgets and senior healthcare spending. Policy adjustments may continue as lawmakers respond to market reactions.

Experts also expect more transparency efforts around drug pricing in coming years. Greater disclosure of rebate systems and negotiated prices could improve consumer awareness. However, transparency alone may not immediately reduce costs at the pharmacy counter. Seniors may still face uneven savings depending on their medication needs and plan structure. The next few years will likely bring gradual change rather than quick relief.

What This Means for Seniors on Fixed Incomes

Rising Part D costs create ongoing challenges for seniors who rely on stable retirement budgets. Even with new reform rules, real-world savings vary widely depending on medication type and insurance plan design. Fixed incomes struggle to keep pace with rising premiums, copays, and specialty drug expenses. Careful plan selection and annual review remain essential tools for managing these changes. Small decisions, like pharmacy choice or generic substitution, can make a noticeable difference over time. The system continues to evolve, but personal strategy still plays a major role in controlling costs.

How have rising prescription costs affected retirement budgeting and medication decisions? Share your thoughts and experiences in the comments below.

You May Also Like…

Original Medicare vs. Advantage: More Retirees Are Switching Back — And Here’s Why

The 2027 Social Security COLA Is Surging—But Seniors May Not Be Better Off

The Medicare Premium Increase That Could Consume Nearly One-Third of Some Retirees’ COLA Boost

6 Medicare Advantage Changes That Could Surprise Seniors in the Next Enrollment Cycle

Ohio Retirees Are Paying More for Prescription Drugs Even After Medicare Reform Changes

Brandon Marcus
Brandon Marcus

Brandon Marcus is a writer who has been sharing the written word since a very young age. His interests include sports, history, pop culture, and so much more. When he isn’t writing, he spends his time jogging, drinking coffee, or attempting to read a long book he may never complete.

Filed Under: Lifestyle Tagged With: healthcare inflation, Inflation Reduction Act, Medicare changes, Medicare Part D, prescription drug costs, retirement budgeting, senior finances

Follow Us

Search this site:

Recent Posts

  • Can My Savings Account Affect My Financial Aid? by Tamila McDonald
  • 12 Ways Gen X’s Views Clash with Millennials… by Tamila McDonald
  • What Advantages and Disadvantages Are There To… by Jacob Sensiba
  • 10 Tactics for Building an Emergency Fund from Scratch by Vanessa Bermudez
  • Call 911: Go To the Emergency Room Immediately If… by Stephen Kanaval
  • 7 Weird Things You Can Sell Online by Tamila McDonald
  • 10 Scary Facts About DriveTime by Tamila McDonald

Copyright © 2026 · News Pro Theme on Genesis Framework